BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27146087)

  • 21. Preventing, treating, and predicting barbering: A fundamental role for biomarkers of oxidative stress in a mouse model of Trichotillomania.
    Vieira GLT; Lossie AC; Lay DC; Radcliffe JS; Garner JP
    PLoS One; 2017; 12(4):e0175222. PubMed ID: 28426681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetylcysteine in trichotillomania: further thoughts.
    Goulding JMR
    Br J Dermatol; 2015 Jun; 172(6):1683-1684. PubMed ID: 25640599
    [No Abstract]   [Full Text] [Related]  

  • 23. Alternative Therapies for Excoriation (Skin Picking) Disorder: A Brief Update.
    Torales J; Barrios I; Villalba J
    Adv Mind Body Med; 2017 Winter; 31(1):10-13. PubMed ID: 28183072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-acetyl cysteine in the treatment of trichotillomania.
    França K; Lotti T
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 27891708
    [No Abstract]   [Full Text] [Related]  

  • 25. Antioxidant Therapies for Ulcerative Dermatitis: A Potential Model for Skin Picking Disorder.
    George NM; Whitaker J; Vieira G; Geronimo JT; Bellinger DA; Fletcher CA; Garner JP
    PLoS One; 2015; 10(7):e0132092. PubMed ID: 26167859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder and comorbid trichotillomania: a preliminary report.
    Golubchik P; Sever J; Weizman A; Zalsman G
    Clin Neuropharmacol; 2011; 34(3):108-10. PubMed ID: 21586916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is trichotillomania a stereotypic movement disorder? An analysis of body-focused repetitive behaviors in people with hair-pulling.
    Stein DJ; Flessner CA; Franklin M; Keuthen NJ; Lochner C; Woods DW
    Ann Clin Psychiatry; 2008; 20(4):194-8. PubMed ID: 19034750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A girl with self-harm treated with N-acetylcysteine (NAC)].
    Rus CP
    Tijdschr Psychiatr; 2017; 59(3):181-184. PubMed ID: 28350146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling).
    Swedo SE; Leonard HL; Rapoport JL; Lenane MC; Goldberger EL; Cheslow DL
    N Engl J Med; 1989 Aug; 321(8):497-501. PubMed ID: 2761586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania.
    Streichenwein SM; Thornby JI
    Am J Psychiatry; 1995 Aug; 152(8):1192-6. PubMed ID: 7625469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clomipramine treatment of trichotillomania: a follow-up report on four cases.
    Pollard CA; Ibe IO; Krojanker DN; Kitchen AD; Bronson SS; Flynn TM
    J Clin Psychiatry; 1991 Mar; 52(3):128-30. PubMed ID: 2005076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
    Mousavi SG; Sharbafchi MR; Salehi M; Peykanpour M; Karimian Sichani N; Maracy M
    Arch Iran Med; 2015 Jan; 18(1):28-33. PubMed ID: 25556383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania.
    Christenson GA; Mackenzie TB; Mitchell JE; Callies AL
    Am J Psychiatry; 1991 Nov; 148(11):1566-71. PubMed ID: 1928474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium treatment of chronic hair pulling.
    Christenson GA; Popkin MK; Mackenzie TB; Realmuto GM
    J Clin Psychiatry; 1991 Mar; 52(3):116-20. PubMed ID: 1900831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A patient-tailored N-acetylcysteine protocol for acute acetaminophen intoxication.
    Tsai CL; Chang WT; Weng TI; Fang CC; Walson PD
    Clin Ther; 2005 Mar; 27(3):336-41. PubMed ID: 15878387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trichotillomania Triggered by Vitamin D Deficiency and Resolving Dramatically With Vitamin D Therapy.
    Akaltun İ
    Clin Neuropharmacol; 2019; 42(1):20-21. PubMed ID: 30649027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trichotillomania: What Do We Know So Far?
    Melo DF; Lima CDS; Piraccini BM; Tosti A
    Skin Appendage Disord; 2022 Jan; 8(1):1-7. PubMed ID: 35118122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring pharmacological treatment for trichotillomania: do we need better education?
    Krajewski PK; Zirpel H; Saceda-Corralo D; Thaçi D; Szepietowski JC
    Int J Dermatol; 2024 May; ():. PubMed ID: 38797877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoxetine for trichotillomania: an open clinical trial.
    Koran LM; Ringold A; Hewlett W
    Psychopharmacol Bull; 1992; 28(2):145-9. PubMed ID: 1513916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.
    Deepmala ; Slattery J; Kumar N; Delhey L; Berk M; Dean O; Spielholz C; Frye R
    Neurosci Biobehav Rev; 2015 Aug; 55():294-321. PubMed ID: 25957927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.